Screening for hydroxychloroquine retinal toxicity: Is it necessary?
- 1 July 1990
- journal article
- Published by Springer Nature in Eye
- Vol. 4 (4) , 572-576
- https://doi.org/10.1038/eye.1990.79
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Hydroxychloroquine Therapy in Massive Total Doses Without Retinal ToxicityAmerican Journal of Ophthalmology, 1987
- Screening for antimalarial maculopathy in rheumatology clinics.BMJ, 1985
- Hydroxychloroquine in the treatment of rheumatoid arthritisThe American Journal of Medicine, 1983
- Ophthalmologic safety of long-term hydroxychloroquine sulfate treatmentThe American Journal of Medicine, 1983
- Ophthalmologic considerations and testing in patients receiving long-term antimalarial therapyThe American Journal of Medicine, 1983
- Dose refinements in long-term therapy of rheumatoid arthritis with antimalarialsThe American Journal of Medicine, 1983
- Chloroquine retinopathy: is there a safe daily dose?Annals of the Rheumatic Diseases, 1982
- Chloroquine: Ophthalmological Safety, and Clinical Assessment in Rheumatoid ArthritisBMJ, 1968
- Ocular Changes Induced by Long-Term Hydroxychloroquine (Plaquenil) TherapyAmerican Journal of Ophthalmology, 1967
- Ocular Lesions in Rheumatoid Arthritis and Related Disorders with Particular Reference to RetinopathyNew England Journal of Medicine, 1965